List your tool

Head to head · 2026

Immunai vs JADBio

Pricing, free plans, ratings, features, pros and cons, side by side. Where one comes out ahead, we mark it.

Immunai

AI platform mapping the human immune system at single-cell resolution to accelerate drug discovery for pharma…

4.0Not listed

Visit Immunai (opens Immunai in a new tab)

JADBio

AutoML built specifically for biological and molecular data, aimed at biomarker discovery by researchers rather than…

3.9Free

Visit JADBio (opens JADBio in a new tab)

Who comes out ahead

Based only on the facts in our directory. The right pick still depends on the job you need done.

  • Lower starting price

    Not comparable

    Not comparable: Immunai does not list a price

  • Free plan

    JADBio

    Only JADBio has one

  • Higher rating

    Immunai

    4.0 against 3.9

  • Same job?

    Yes

    Both are Healthcare AI tools

Side by side

Compared onImmunaiJADBio
Our rating4.0Better3.9
Starts atNot listedFree
Free planNoYesBetter
CategoryHealthcare AIHealthcare AI
PlansSee pricingFree
Key features
  • AMICA-OS platform built on single-cell multi-omic immune system data
  • Target discovery tools for identifying new drug candidates from immune cell behavior
  • Preclinical evaluation modeling for testing target hypotheses before trials
  • Clinical trial optimization using immune-response data
  • One of the industry's largest clinical immunology datasets, built through 30-plus pharma partnerships
  • AutoML tuned for biological and molecular data
  • Biomarker discovery workflows
  • Survival analysis support
  • GUI for researchers plus an API
  • Available on the AWS Marketplace
Pros
  • Dataset scale, built through partnerships with Fortune 100 pharma companies, gives its models depth smaller labs can't replicate
  • Covers the full pipeline from target discovery through clinical trial optimization rather than one narrow step
  • Named partnerships with AstraZeneca, Boehringer Ingelheim, Pfizer, and Novo Nordisk demonstrate real commercial traction
  • Handles omics data properties that break general AutoML tooling
  • Usable by researchers without a data science team
  • Survival analysis included, which general platforms usually lack
Cons
  • No published pricing; every engagement is a custom partnership negotiation
  • Built exclusively for pharmaceutical R&D, inaccessible to academic labs or individual researchers without a deal
  • Value depends on data-sharing arrangements with partners, which take time to negotiate and set up
  • A computationally discovered biomarker is a hypothesis, not a finding
  • Independent cohort validation is still required
  • Narrow domain - no use outside life sciences data
CompanyImmunai, founded 2018JADBio

Prices come from each vendor's pricing page, last checked 20260901. Check the vendor before you buy.

FAQ

Questions people ask

Is Immunai better than JADBio?

In our reviews Immunai scores 4.0 and JADBio scores 3.9. The better pick depends on the job. Immunai: AI platform mapping the human immune system at single-cell resolution to accelerate drug discovery for pharma partners. JADBio: AutoML built specifically for biological and molecular data, aimed at biomarker discovery by researchers rather than data scientists.

Which is cheaper, Immunai or JADBio?

Immunai: see pricing. JADBio: free.

Do Immunai and JADBio have free plans?

Only JADBio has a free plan.

More comparisons